Health Sciences Acquisitions, a blank check company formed by RTW Investments to acquire a biopharma or medical technology business, raised $100 million by offering 10 million units at $10, as expected. Each unit consists of one share of common stock and one warrant to purchase one-half of one share of common stock.
Health Sciences Acquisitions plans to list on the Nasdaq under the symbol HSACU. Chardan Capital Markets and UBS Investment Bank acted as lead managers on the deal.
